Myriad Sues Again To Block Rival Gene-Based Cancer Test
Myriad Genetics Inc. on Wednesday filed a second patent infringement lawsuit in as many days over recently launched cancer-testing products, this time alleging that lower-cost genetic testing offered by Gene By...To view the full article, register now.
Already a subscriber? Click here to view full article